Sree Kant, MBA. MPH
Company: Life Biosciences
Job title: Head of Business Development
Sree Kant is Head of Business development at Life Biosciences and drives new scientific investments and strategic partnerships for Life. He has a diverse 18 years healthcare and pharmaceutical industry experience as an investor, advisor and in operational roles.
Sree has been the head of Early Partnering Strategy for Pfizer, working across different therapeutic areas/technologies and geographies. He was responsible for strategic partnerships with Academia, VCs/Banks, CROs, and other strategic partners, from early stage discovery to human proof of concept. He successfully lead the development of Pfizer’s Gene Therapy strategy, as well as the development of Pfizer’s early stage Innovative Target Exploration Networks (ITENs). Sree has also been a Principal at the Boston Consulting Group advising large pharma and biotech on R&D strategy, corporate development, organizational transformations, partnering strategy as well as large M&A and post-merger integrations. In addition, Sree was part of two healthcare startups (in Bangalore and New York) where he led the overall business agenda.
Sree has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health. He is an invited speaker at key industry events and conferences on subjects of R&D strategy, innovative partnering models, industry-academia collaborations, early-stage technologies and investments, etc.
Innovating R&D for Ageing: A Systematic, Comprehensive & Innovative Approach to The Development of Therapies for Ageing 1:30 pm
Analyzing the fragmentated clinical translation of pathways that control biological ageing Discussing current business/investment models in R&D and the their short comings as applicable to ageing research Developing an innovative drug development engine for ageing – establishing Life Biosciences Discussing the Life Bioscience’s investment and operating model, the science underlying the programs, and how we…Read more
day: Day Two